Infants Given the RSV Antibody Received Fewer Antibiotic Prescriptions, Philadelphia Study Finds
A study of 15,341 infants found that nirsevimab recipients received fewer antibiotics for respiratory infections, a benefit beyond RSV prevention.
Medical Daily ·